Novo's new obesity therapy Wegovy is significantly expanding the obesity treatment market given its strong efficacy and is poised to remain a key drug in the market until patent expiration in 2032.

The second day of the 11th Bhopal Science Fair was filled with engaging discussions, insightful lectures, and vibrant cultural performances. The day kicked off with a student dialogue session ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Novo Nordisk's GLP-1 receptor agonist semaglutide ... The topline results from the ESSENCE trial of semaglutide showed that a once-weekly 2.4mg dose of the drug was better than placebo at ...

told the meeting that the promising results justify further research and a larger phase 2 trial is planned for the second half of this year, with results expected in around 2026. Novo Nordisk’s ...

Here are all the latest rumors, plus plenty of carefully considered speculation, about the Nintendo Switch 2. Although the Nintendo Switch 2 has yet to be officially revealed, though Nintendo has ...

With that in mind, here are all the rumors we've heard about the Nintendo Switch 2 and what we’d like to see. This original rumor suggested that Nintendo had moved the release date of its next ...

Squid Game Season 2 is here, and it’s packed with exciting new deadly challenges that take the stakes to a whole new level. Fans were excited to see if the main character, Seong Gi-hun, would go ...

Squid Game Season 2 is reigning supreme at Netflix and raking in rave reviews worldwide. However, while the first season of Squid Game consisted of nine long and detailed episodes, the second ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...